Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases
Cheng Yang,Cheng-Gang Zhu,Yuan-Lin Guo,Na-Qiong Wu,Qian Dong,Rui-Xia Xu,Yong-Jian Wu,Jie Qian,Jian-Jun Li
DOI: https://doi.org/10.4093/dmj.2023.0410
2024-08-23
Diabetes & Metabolism Journal
Abstract:1 Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Copyright © 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Download PDF CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. AUTHOR CONTRIBUTIONS Conception or design: C.Y., J.Q., J.J.L. Acquisition, analysis, or interpretation of data: C.Y., C.G.Z., Y.L.G., N.Q.W., Q.D., R.X.X. Drafting the work or revising: Y.J.W., J.Q., J.J.L. Final approval of the manuscript: J.Q., J.J.L. FUNDING This work was supported by CAMS Innovation Fund for Medical Sciences (CIFMS) (2022-12M-C&T-B-043). Values are presented as mean±standard deviation, number (%), or median (interquartile range). BMI, body mass index; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; NT-proBNP, N-terminal pro–B-type natriuretic peptide; PCI, percutaneous coronary artery intervention; CABG, coronary artery bypass grafting. Univariate and multivariate Cox proportional hazards regression analysis was performed in crude and adjusted models respectively. Model adjusted for age, sex, body mass index, current smoking, hypertension, peripheral artery disease, family history of coronary artery disease, left ventricular ejection fraction, glycosylated hemoglobin, N-terminal pro–B-type natriuretic peptide, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, lipoprotein(a), fibrinogen, diseased vessels, and baseline statins, aspirin, angiotensin II receptor blockers, β-blockers, and calcium channel blockers treatments. ET-1, endothelin-1; HR, hazard ratio; CI, confidence interval. a P <0.05. Univariate and multivariate Cox proportional hazards regression analysis was performed in crude and adjusted models respectively. Model adjusted for age, sex, body mass index, current smoking, hypertension, peripheral artery disease, family history of coronary artery disease, left ventricular ejection fraction, N-terminal pro–B-type natriuretic peptide, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, lipoprotein(a), fibrinogen, diseased vessels, and baseline statins, aspirin, angiotensin II receptor blockers, β-blockers, and calcium channel blockers treatments. ET-1, endothelin-1; HR, hazard ratio; CI, confidence interval. a P <0.05.
endocrinology & metabolism